Pharmacokinetics of cefpirome following intravenous and intramuscular administrations in healthy and febrile sheep (Ovis aries)

VAIDEHI N SARVAIYA; KAMLESH A SADARIYA; SHAILESH K BHAVSAR; ASWIN M THAKER; RAKESH J MODI

doi:10.56093/ijans.v93i8.125060

Authors

VAIDEHI N SARVAIYA College of Veterinary Science and Animal Husbandry, Kamdhenu University, Sardarkrushinagar-385506
KAMLESH A SADARIYA College of Veterinary Science and Animal Husbandry, Kamdhenu University, Anand 388001 Gujarat, India
SHAILESH K BHAVSAR College of Veterinary Science and Animal Husbandry, Kamdhenu University, Anand 388001 Gujarat, India
ASWIN M THAKER College of Veterinary Science and Animal Husbandry, Kamdhenu University, Anand 388001 Gujarat, India
RAKESH J MODI College of Veterinary Science and Animal Husbandry, Kamdhenu University, Anand 388001 Gujarat, India

https://doi.org/10.56093/ijans.v93i8.125060

Keywords:

Pharmacokinetic, Pharmacodynamic, Cefpirome sulfate, Febrile, Sheep

Abstract

Cefpirome is fourth generation cephalosporin class of drug, which facilitates rapid penetration through the outer membrane of Gram-negative bacteria and results in potent activity against Gram-negative pathogens. As fever is one of the most common manifestations in bacterial diseases, the study was undertaken to investigate pharmacokinetics of single dose intravenous and intramuscular administrations of cefpirome (10 mg/kg of body weight) in healthy and lipopolysaccharide (LPS) induced febrile sheep as well as to perform PK-PD analysis using MIC values reported in previous studies and the pharmacokinetic parameters obtained in this study. Following intravenous and intramuscular administrations of cefpirome in healthy sheep, the plasma drug concentration was detected up to 12 h, while plasma drug concentration was detected up to 18 h following intravenous and intramuscular administrations in febrile sheep. Induction of febrile state significantly altered pharmacokinetic profile of cefpirome including significant increase
in the mean values of t½β, AUC0-∞ and MRT while significant decrease in the mean values of Vdarea, Vdss following intravenous administration, while significant decrease in the mean values of Vdarea and ClB, whereas significant increase in the mean values of t½β, Cmax, AUC0-∞ and MRT following intramuscular administration of cefpirome as compared to their respective mean values in healthy sheep. Based on pharmacokinetic-pharmacodynamic integration, an optimal intramuscular dosage regimen of 10 mg/kg once daily for cefpirome in febrile sheep was predicted for targeted average MIC of ≤ 0.25 μg/mL.

Downloads

Download data is not yet available.

References

Agrawal A K, Singh S D and Jayachandran C. 2002. Comparative pharmacokinetics and dosage regimen of amikacin in afebrile and febrile goats. Indian Journal of Pharmacology 34: 356-60.

Balaban N Q, Helaine S, Lewis K, Ackermann M, Aldridge B, Andersson D I, Brynildsen M P, Bumann D, Camilli A, Collins J J, Dehio C, Fortune S, Ghigo J, Hardt W, Harms A, Heinemann M, Hung D T, Jenal U, Levin B R, Michiels J, Storz G, Tan M, Tenson T, Van Melderen L and Zinkernagel A. 2019. Definitions and guidelines for research on antibiotic persistence. Nature Reviews Microbiology 17(7): 441–48. DOI: https://doi.org/10.1038/s41579-019-0196-3

Connors K P, Kuti J L and Nicolau D P. 2013. Optimizing antibiotic pharmacodynamics for clinical practice. Pharmaceutica Analytica Acta 4(3): 1-8.

Corcione S, Lupia T and De Rosa F G. 2021. Novel cephalosporins in septic subjects and severe infections: Present findings and future perspective. Frontiers in Medicine 8: 617378. DOI: https://doi.org/10.3389/fmed.2021.617378

Craig W A and Andes D R. 2015. Cephalosporins. In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious diseases. (8th Ed.). pp. 278-92. Philadelphia: Churchill Livingstone Elsevier. DOI: https://doi.org/10.1016/B978-1-4557-4801-3.00021-7

Craig W A. 1998. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clinical Infectious Diseases 26: 1-12. DOI: https://doi.org/10.1086/516284

Craig W A. 2003. Basic pharmacodynamics of antibacterials with clinical applications to the use of beta-lactams, glycopeptides, and linezolid. Infectious Disease Clinics of North America 17: 479-501. DOI: https://doi.org/10.1016/S0891-5520(03)00065-5

El-Radhi A S. 2019. Pathogenesis of fever. Clinical Manual of Fever in Children 2: 53-68. DOI: https://doi.org/10.1007/978-3-319-92336-9_3

Goudah A, Mouneir S M, Shim J H and El-Aty A M A. 2006. Influence of endotoxin induced fever on the pharmacokinetics of intramuscularly administered cefepime in rabbits. Journal of Veterinary Science 7(2): 151-55. DOI: https://doi.org/10.4142/jvs.2006.7.2.151

Joshi B and Sharma S K. 2009. The pharmacokinetics of cefepime in E. coli lipopolysaccharide induced febrile buffalo calves. Veterinarski Arhiv 79(6): 523-30.

Mujeeb M M A and Jalikar K. 2015. Pharmacokinetic study of cefpirome: Fourth generation cephalosporin. Journal of Evolution of Medical and Dental Sciences 4(68): 11834-40. DOI: https://doi.org/10.14260/jemds/2015/1706

Mustafa S, Elgazzar A H, Essam H, Gopinath S and Mathew M. 2007. Hyperthermia alters kidney function and renal scintigraphy. American Journal of Nephrology 27: 315-21. DOI: https://doi.org/10.1159/000102597

Patel H B, Patel M N, Patel S D, Dewda S, Patel J H, Bhavsar S K and Thaker A M. 2012b. Effect of ketoprofen co-administration and febrile state on pharmacokinetic of cefepime in goats. Asian Journal of Animal and Veterinary Advances 7: 46-53. DOI: https://doi.org/10.3923/ajava.2012.46.53

Patel N M, Patel H B, Patel S D, Patel J H, Bhavsar S K and Thaker A M. 2012a. Effect of ketoprofen co-administration or febrile state on pharmacokinetic of cefepime in sheep. Veterinarski Arhiv 82(5): 473-81.

Rajput N, Dumka V K and Sandhu H S. 2011. Pharmacokinetics and dosage regimen of cefpirome in febrile cross-bred calves. Iranian Journal of Pharmacology and Therapeutics 10: 17-20.

Rodriguez-Gascon A, Solinis M A and Isla A. 2021. The role of PK/PD analysis in the development and evaluation of antimicrobials. Pharmaceutics 13(6): 833-60. DOI: https://doi.org/10.3390/pharmaceutics13060833

Sharma S K and Ul Haq S A. 2012. The pharmacokinetics of ceftazidime in E. coli lipopolysaccharide induced febrile buffalo calves. Veterinarski Arhiv 82(6): 555-65.

Smith D A, Di L and Kerns E H. 2010. The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery. Nature Reviews Drug Discovery 9(12): 929-39. DOI: https://doi.org/10.1038/nrd3287

Strenkoski L C and Nix D E. 1993. Cefpirome clinical pharmacokinetics. Clinical Pharmacokinetics 25(4): 263-73. DOI: https://doi.org/10.2165/00003088-199325040-00002

Turnidge J D. 1998. The pharmacodynamics of beta-lactams. Clinical Infectious Diseases 27: 10–22. DOI: https://doi.org/10.1086/514622

Verma D K and Roy B K. 2006. Milk kinetics of gatifloxacin after single dose intravenous administration in healthy and febrile goats. Indian Journal of Pharmacology 38: 366-67. DOI: https://doi.org/10.4103/0253-7613.27711